Smoking Cessation Therapy Therapeutics
1. Chantix patent expiration
Treatment: Aid to smoking cessation
CHANTIX IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7265119 | PF PRISM CV | Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
Aug, 2022
(3 years ago) | |
|
US6410550 (Pediatric) | PF PRISM CV | Aryl fused azapolycyclic compounds |
Nov, 2020
(5 years ago) | |
|
US6890927 (Pediatric) | PF PRISM CV | Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
Nov, 2022
(3 years ago) | |
|
US7265119 (Pediatric) | PF PRISM CV | Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
Feb, 2023
(2 years ago) | |
| US6410550 | PF PRISM CV | Aryl fused azapolycyclic compounds |
May, 2020
(5 years ago) | |
| US6890927 | PF PRISM CV | Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
May, 2022
(3 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-105) | Jul 22, 2014 |
| M(M-143) | Oct 15, 2017 |
| M(M-144) | Oct 15, 2017 |
| M(M-183) | Aug 12, 2019 |
| M(M-192) | Dec 16, 2019 |
| M(M-237) | Feb 22, 2022 |
| Pediatric Exclusivity(PED) | Aug 22, 2022 |
Drugs and Companies using VARENICLINE TARTRATE ingredient
Market Authorisation Date: 10 May, 2006
Dosage: TABLET
How can I launch a generic of CHANTIX before it's drug patent expiration?
More Information on Dosage
CHANTIX family patents
